title: Telomere length changes in patients undergoing hematopoietic stem cell transplantation.
abstract: Telomere length indicates the replicative history of cells, serving as a molecular measure of the replicative potential remaining in cells. To investigate telomere length changes in hematopoietic stem cells, patients undergoing hematopoietic stem cell transplantation (HSCT) were evaluated. Fifteen patients after allogeneic bone marrow transplantation (allo-BMT group), seven patients after autologous peripheral blood stem cell transplantation (auto-PBSCT group), and 39 healthy controls were studied. Telomere length was measured in peripheral mononuclear cells by Southern blot hybridization. There was no significant difference between the allo-BMT and the auto-PBSCT groups. In the allo-BMT group, the mean telomere length of recipients was 2.01 kb shorter than that of their donors (P = 0. 008), and was 1.59 kb shorter than that of age-matched putative normal controls (P = 0.002). Telomere shortening in the allo-BMT group was equivalent to 41.4 years of aging in the donors, and to 52. 4 years of aging in the normal controls. The mean telomere length in the auto-PBSCT group was 2.36 kb shorter than that of the age-matched putative controls (P = 0.043), which was equivalent to 61.5 years of aging in normal controls. The extent of telomere shortening in the allo-BMT group showed a trend to negative correlation with the number of mononuclear cells infused. These findings suggest that hematopoietic stem cells after HSCT lose telomere length and these shortened telomeres may result in a higher incidence of clonal disorders later in life.
authors.affiliation: Blood and Marrow Transplant Program, Chonnam National University Medical School, Kwangju, Korea.
authors.forename: J
authors.initials: J
authors.lastname: Lee
authors.forename: H
authors.initials: H
authors.lastname: Kook
authors.forename: I
authors.initials: I
authors.lastname: Chung
authors.forename: H
authors.initials: H
authors.lastname: Kim
authors.forename: M
authors.initials: M
authors.lastname: Park
authors.forename: C
authors.initials: C
authors.lastname: Kim
authors.forename: J
authors.initials: J
authors.lastname: Nah
authors.forename: T
authors.initials: T
authors.lastname: Hwang
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007938:Leukemia / Q000097:blood / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012016:Reference Values; D012044:Regression Analysis; D016615:Telomere / Q000473:pathology / Q000648:ultrastructure*; D014019:Tissue Donors; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D014923:Wiskott-Aldrich Syndrome / Q000097:blood / Q000473:pathology / Q000628:therapy*